International Journal of Molecular Sciences (Jan 2022)

Heat Shock Protein 90 as Therapeutic Target for CVDs and Heart Ageing

  • Siarhei A. Dabravolski,
  • Vasily N. Sukhorukov,
  • Vladislav A. Kalmykov,
  • Nikolay A. Orekhov,
  • Andrey V. Grechko,
  • Alexander N. Orekhov

DOI
https://doi.org/10.3390/ijms23020649
Journal volume & issue
Vol. 23, no. 2
p. 649

Abstract

Read online

Cardiovascular diseases (CVDs) are the leading cause of death globally, representing approximately 32% of all deaths worldwide. Molecular chaperones are involved in heart protection against stresses and age-mediated accumulation of toxic misfolded proteins by regulation of the protein synthesis/degradation balance and refolding of misfolded proteins, thus supporting the high metabolic demand of the heart cells. Heat shock protein 90 (HSP90) is one of the main cardioprotective chaperones, represented by cytosolic HSP90a and HSP90b, mitochondrial TRAP1 and ER-localised Grp94 isoforms. Currently, the main way to study the functional role of HSPs is the application of HSP inhibitors, which could have a different way of action. In this review, we discussed the recently investigated role of HSP90 proteins in cardioprotection, atherosclerosis, CVDs development and the involvements of HSP90 clients in the activation of different molecular pathways and signalling mechanisms, related to heart ageing.

Keywords